Home » Newsletters » BioWorld Science

BioWorld Science

April 5, 2017

View Archived Issues

Phase I study to compare safety and pharmacokinetics of NVP-1402 and NVP-1402R

Potent PI3Kdelta inhibitors for the treatment of inflammatory and autoimmune diseases

MicroQuin describes cancer candidates MQ-001 and MQ-002

RepliCel Life Sciences reports interim data from phase I study of RCS-01

FDA accepts for review sNDA seeking approval of ibrutinib in chronic GvHD

Bristol-Myers Squibb presents prodrug of BMT-1438 for the treatment of rheumatoid arthritis

DuPont announces business transaction agreement with FMC

Amgen seeks to expand current indication for Xgeva to include patients with multiple myeloma

BAY-1816032, a novel BUB1 inhibitor with potent antitumor activity

FDA grants priority review to sBLA for Opdivo in colorectal cancer

RedHill Biopharma's ABC-294640 receives FDA orphan drug designation for cholangiocarcinoma

Intralytix and BioPhage to develop topical bacteriophage treatment for S. aureus-infected wounds

Meiji Seika Pharma and Eisai sign licensing agreement for safinamide in Japan and Asia

Pharmacokinetics and pharmacodynamics of AG-B1512 in preclinical models reported

Evotec reaches first milestone in diabetes collaboration with Sanofi

Roche presents Toll-like receptor 8 agonists

Merck KGaA discloses ASIC1 inhibitors

QIAGEN obtains license to RNA biomarker from Johns Hopkins

Janssen Pharmaceuticals and collaborator divulge dengue virus replication inhibitors

BloodCenter of Wisconsin launches more precise VWF test in U.S.

Pharmascience discovers Tec family kinase inhibitors

AB Science identifies SYK kinase inhibitors

X4-136 in combination therapy with anti-PD-1 improves survival in murine ovarian cancer model

Phase I/II trial of a novel vaccine candidate AV-0328

NantKwest and Viracta Therapeutics close series B financing, enter partnership

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...